Plunkett Research Online: UCB SA

UCB SA (UCBJF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

UCB SA is a Belgian biopharmaceutical firm with operations in more than 40 countries. The firm’s main products are focused within the fields of immunology and neurology. UCB’s immunology product is used to treat rheumatoid arthritis, osteoporosis, axial spondyloarthritis, psoriatic arthritis, Chro.....



UCB SA
Ticker: UCBJF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 32-2-559-99-99
Fax: 32-2-559-99-00
Address: 60, Allee de la Recherche
Brussels, 1070 Belgium

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Development
Industrial Chemical Products
Allergy & Respiratory Treatments
Central Nervous System Disorder Treatments
ContactsDescription

Jean-Christophe TellierCEO
Detlef ThielgenCFO/Exec. VP
See More
UCB SA is a Belgian biopharmaceutical firm with operations in more than 40 countries. The firm’s main products are focused within the fields of immunology and neurology. UCB’s immunology product is used to treat rheumatoid arthritis, osteoporosis, axial spondyloarthritis, psoriatic arthritis, Chro.....See More See More

Auditor: PwC Reviseurs d'Entreprises sccrl
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Cimzia
Briviact
Keppra
Vimpat
Neupro
Nootropil
Xyrem
Element Genomics
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: